Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats

Elbadawy, Hossein M., Almikhlafi, Mohannad A., Alsubhi, Mohammed H., Shokry, Aya A., Fayed, Hany M., Mohamed, Bassim M. S. A., Afifi, Sherif M., Esatbeyoglu, Tuba, Korany, Reda M. S., Elbaset, Marawan A.

Open source

DOI
10.15488/21481
Published
2025
Container
Not recorded
Publisher
[Hoboken, NJ : Wiley]
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.15488/21481,
  title = {Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats},
  author = {Elbadawy, Hossein M. and Almikhlafi, Mohannad A. and Alsubhi, Mohammed H. and Shokry, Aya A. and Fayed, Hany M. and Mohamed, Bassim M. S. A. and Afifi, Sherif M. and Esatbeyoglu, Tuba and Korany, Reda M. S. and Elbaset, Marawan A.},
  year = {2025},
  doi = {10.15488/21481},
  url = {https://doi.org/10.15488/21481}
}

RIS

TY  - JOUR
TI  - Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats
AU  - Elbadawy, Hossein M.
AU  - Almikhlafi, Mohannad A.
AU  - Alsubhi, Mohammed H.
AU  - Shokry, Aya A.
AU  - Fayed, Hany M.
AU  - Mohamed, Bassim M. S. A.
AU  - Afifi, Sherif M.
AU  - Esatbeyoglu, Tuba
AU  - Korany, Reda M. S.
AU  - Elbaset, Marawan A.
PY  - 2025
DO  - 10.15488/21481
UR  - https://doi.org/10.15488/21481
ER  - 

APA

M., E. H., A., A. M., H., A. M., A., S. A., M., F. H., A., M. B. M. S., M., A. S., Tuba, E., S., K. R. M., & A., E. M. (2025). Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats. https://doi.org/10.15488/21481

Source records